BioCentury
ARTICLE | Company News

AZ gains on rumored talks with Pfizer

April 21, 2014 11:57 PM UTC

AstraZeneca plc (LSE:AZN; NYSE:AZN) gained $5.61 to $69.10 in New York on Monday on media reports that the pharma was in "informal, now-discontinued talks" with Pfizer Inc. (NYSE:PFE) for the pharma t...